Incremental Cost Effectiveness of Prophylaxis for Cytomegalovirus Disease in Patients with AIDS

Author： Kempen J.H.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.19, Iss.12, 2001-01, pp. : 1199-1208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incremental Cost-Effectiveness Analysis of Intravenous Ganciclovir Versus Oral Ganciclovir in the Maintenance Treatment of Newly Diagnosed Cytomegalovirus Retinitis in Patients with AIDS

By Rachlis A.  

PharmacoEconomics, Vol. 16, Iss. 1, 1999-07 ,pp. : 71-84

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Prophylaxis for Opportunistic Infections in AIDS: An Overview and Methodological Discussion

By Freedberg K.A.  

PharmacoEconomics, Vol. 14, Iss. 2, 1998-08 ,pp. : 165-174

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Model of Cytomegalovirus Management Strategies in Renal Transplantation: Comparing Valaciclovir Prophylaxis with Current Practice

By Mauskopf J.A.  

PharmacoEconomics, Vol. 18, Iss. 3, 2000-09 ,pp. : 239-251

Adis International

Access to resources Recommend Favorite

Cost Benefit and Cost Effectiveness of Antifungal Prophylaxis in Immunocompromised Patients Treated for Haematological Malignancies: Reviewing the Available Evidence

By Pechlivanoglou Petros  

PharmacoEconomics, Vol. 29, Iss. 9, 2011-09 ,pp. : 737-751

Adis International

Access to resources Recommend Favorite

Cost-effectiveness of antibiotic prophylaxis for bacterial arthritis

By Krijnen Pieta   Schaardenburg Dirkjan van   Kaandorp Carola  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 3, 2002-03 ,pp. : 271-275

Informa Healthcare

Access to resources Recommend Favorite